Possibilities for therapeutic interventions in disrupting Chlamydophila pneumoniae involvement in atherosclerosis.
about
Construction of a highly flexible and comprehensive gene collection representing the ORFeome of the human pathogen Chlamydia pneumoniaeChlamydia pneumoniae and oxidative stress in cardiovascular disease: state of the art and prevention strategiesThe prevention and regression of atherosclerotic plaques: emerging treatments.A novel transport mechanism for MOMP in Chlamydophila pneumoniae and its putative role in immune-therapyInfection and Atherosclerosis DevelopmentChlamydophila pneumoniae infection and cardiovascular diseasePersistent C. pneumoniae infection in atherosclerotic lesions: rethinking the clinical trials.Chlamydia pneumoniae infection in atherosclerotic lesion development through oxidative stress: a brief overview.Endothelial cell death and intimal foam cell accumulation in the coronary artery of infected hypercholesterolemic minipigs.Berberine inhibits HEp-2 cell invasion induced by Chlamydophila pneumoniae infection.The role of complement in the development and manifestation of murine atherogenic inflammation: novel avenues.Alternative therapies for diabetes and its cardiac complications: role of vanadium.Periodontal bacterial invasion and infection: contribution to atherosclerotic pathology.Dietary modulation of oxylipins in cardiovascular disease and aging.Periodontal bacterial invasion and infection: contribution to atherosclerotic pathology.A cynomolgus monkey model of carotid atherosclerosis induced by puncturing and scratching of the carotid artery combined with a high-fat diet.: An Etiologic Agent for Late-Onset Dementia
P2860
Q21266688-C9CE4A8A-5CC0-4FF5-882F-4A1D5AD16329Q27009367-FC99433C-16B9-4FD2-B032-A6F64E032D5FQ27691367-7E4AB25A-6490-45EF-9C4B-B18E0B7074C2Q30155102-8EB6D8D3-C366-4927-B60A-B39C969C6108Q35915081-B283F438-B2DB-4C2E-9175-AED5047F031AQ36783331-4906B3DA-C127-4B38-B041-065CF1EBE8E4Q37844575-9DDD6F63-F4FB-4922-A100-A732C66C1C0CQ37846181-31BC62EF-4DB4-4E11-AAA8-9CB090285C28Q37846710-325EFB7F-2C67-4211-8510-5C7567C301FBQ37849872-BA5AA74E-9EAC-43D1-8E51-181ECDBFB3C4Q37960811-BA008521-C2EE-4057-8F1D-EF3B2831FFFCQ38083573-33A9BD83-6F59-4A44-BD28-B2A8FFA4F751Q38102720-6F83EA71-C3CE-4D2C-8116-953DC5AF1DEAQ48157381-3851004D-8C18-4981-97AC-C13AE29CB9D7Q53738748-893FC59D-68D2-42B1-920C-5C6BE5EAE8A1Q55420273-CC840D0F-A7F7-40D2-8E15-F23E5ED2E014Q57816571-3B47D55E-6FB2-4F1D-B5CD-719E7E2777EE
P2860
Possibilities for therapeutic interventions in disrupting Chlamydophila pneumoniae involvement in atherosclerosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Possibilities for therapeutic ...... nvolvement in atherosclerosis.
@en
Possibilities for therapeutic ...... nvolvement in atherosclerosis.
@nl
type
label
Possibilities for therapeutic ...... nvolvement in atherosclerosis.
@en
Possibilities for therapeutic ...... nvolvement in atherosclerosis.
@nl
prefLabel
Possibilities for therapeutic ...... nvolvement in atherosclerosis.
@en
Possibilities for therapeutic ...... nvolvement in atherosclerosis.
@nl
P2860
P1476
Possibilities for therapeutic ...... nvolvement in atherosclerosis.
@en
P2093
Grant N Pierce
Justin F Deniset
P2860
P304
P356
10.1111/J.1472-8206.2010.00863.X
P577
2010-10-01T00:00:00Z